It was a pleasure to speak with Professor Whitney Stevens (Northwestern University Feinberg School of Medicine, Chicago, IL, US) around aspirin desensitisation in aspirin-exacerbated respiratory disease.
‘Aspirin desensitization for AERD in 2020: An update from the AERD work group.’ was presented at the American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting, February 26-March 1, 2021.
- Could you give us a brief overview of aspirin exacerbated respiratory disease (AERD), its prevalence and clinical presentation? (0:18)
- What are the treatment options for AERD? (1:51)
- What are the potential advantages of aspirin desensitisation followed by resumption of aspirin therapy and who is most likely to benefit? (2:29)
- What are the mechanisms underlying this beneficial effect? (3:37)
- How long are these beneficial effects maintained? (4:07)
Disclosures: Whitney Stevens discloses participating in advisory boards for GlaxoSmithKline, GenenTech, and Bristol Myers Squibb and participating in an educational lecture symposium for GlaxoSmithKline.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of AAAAI 2021 (Virtual).
Share this Video
Related Videos In Rhinosinusitis
Peter Hellings: EUFOREA 2022 Global CRSwNP Awareness Day
touchRESPIRATORY were delighted to catch up with Prof Peter Hellings (Catholic University of Leuven; University Hospitals of Leuven, Leuven, Belgium) to discuss this year’s EUFOREA global CRSwNP awareness day that took place on 20 April 2022 and the importance of physician and patient awareness for improved patient outcomes. Questions Can you highlight the burden of […]
Stella Lee, AAAAI 2021: Results of the SYNAPSE Study
Dr Stella Lee (University of Pittsburgh, Pittsburgh, PA, US) spoke with touchRESPIRATORY around the SYNAPSE study, which investigated the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis with nasal polyps (Clinical Trial Identifier: NCT03085797). The abstract ‘Mepolizumab Improves Health Related Quality of Life for Patients with Chronic Rhinosinusitis with Nasal Polyps: Data from […]
Stella Lee, AAAAI 2021: Current Therapies for the Treatment of Chronic Rhinosinusitis with Nasal Polyps
We were delighted to talk to Dr Stella Lee (University of Pittsburgh, Pittsburgh, PA, US) around the current and future treatment options for chronic rhinosinusitis with nasal polyps. Questions What is the impact of chronic rhinosinusitis with nasal polyps on quality of life, and what are the limitations of current therapies? (0:18) What biologics are […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!